Literature DB >> 17197822

CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals.

Gloria von Geldern1, Sabine Cepok, Thorsten Nolting, Yihua Du, Verena Grummel, Ortwin Adams, Hans-Peter Hartung, Gabriele Arendt, Bernhard Hemmer.   

Abstract

Central nervous system involvement is common in HIV infection. We determined the relationship between T-cell subsets and viral load in the cerebrospinal fluid (CSF) of therapy-naive, asymptomatic HIV-infected individuals. A shift from naive to effector-memory CD8 T cells was observed in the CSF of HIV-infected individuals compared with controls. The HIV load strongly correlated with CD8 T cells in CSF. Effector-memory CD8 T cells were positively and effector CD8 T cells were negatively associated with viral replication in CSF.

Entities:  

Mesh:

Year:  2007        PMID: 17197822     DOI: 10.1097/QAD.0b013e328011ec76

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Quantitative MRI Measures in SIV-Infected Macaque Brains.

Authors:  Xiaodong Zhang; Chunxia Li
Journal:  J Clin Cell Immunol       Date:  2013

Review 2.  Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.

Authors:  Michael D Rizzo; Joseph E Henriquez; Lance K Blevins; Anthony Bach; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-14       Impact factor: 4.147

3.  Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.

Authors:  Chun-Xia Li; Xiaodong Zhang; Amelia Komery; Yingxia Li; Hui Mao; James G Herndon; Francis J Novembre
Journal:  J Neurovirol       Date:  2014-11-07       Impact factor: 2.643

4.  Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.

Authors:  M R Lentz; W K Kim; V Lee; S Bazner; E F Halpern; N Venna; K Williams; E S Rosenberg; R G González
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

5.  Enhanced PD-1 expression by T cells in cerebrospinal fluid does not reflect functional exhaustion during chronic human immunodeficiency virus type 1 infection.

Authors:  Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Deborah Sutherland; Rebecca Basham; Husamettin Erdem; Spyros A Kalams; David W Haas
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

6.  Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects.

Authors:  Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Rebecca Basham; Laurie Lebo; Husamettin Erdem; Kirsten Haman; Malcolm Avison; Kevin Waddell; David W Haas; Spyros A Kalams
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

7.  Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.

Authors:  M C Kowarik; V Grummel; S Wemlinger; D Buck; M S Weber; A Berthele; B Hemmer
Journal:  J Neurol       Date:  2013-10-27       Impact factor: 4.849

8.  Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).

Authors:  Rachel D Schrier; Suzi Hong; Melanie Crescini; Ronald Ellis; Josué Pérez-Santiago; Celsa Spina; Scott Letendre
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

Review 9.  Human immunodeficiency virus and multiple sclerosis: a review of the literature.

Authors:  Maria-Ioanna Stefanou; Markus Krumbholz; Ulf Ziemann; Markus C Kowarik
Journal:  Neurol Res Pract       Date:  2019-08-20

10.  Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy.

Authors:  Beret Amundson; Lillin Lai; Mark J Mulligan; Yong Xu; Zidou Zheng; Suprateek Kundu; Jeffrey L Lennox; Drenna Waldrop-Valverde; Donald Franklin; Alison Swaims-Kohlmeier; Scott L Letendre; Albert M Anderson
Journal:  J Neuroimmunol       Date:  2020-04-27       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.